Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Betzler

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|May 23, 2022
T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell DifferentiationAnnika C Betzler, Jasmin Ezić, Tsima Abou Kors, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 31, 2015
[Papillary tumors - therapeutic concepts]F C Popp, J Weigt, T Kalinski, et al.
International Journal of Molecular Sciences|June 4, 2020
NF-κB and Its Role in Checkpoint ControlAnnika C Betzler, Marie-Nicole Theodoraki, Patrick J Schuler, et al.
Journal of Medical Genetics|July 30, 2008
Congenital heart disease is a feature of severe infantile spinal muscular atrophyS Rudnik-Schöneborn, R Heller, C Berg, et al.
Clinical Genetics|September 29, 2009
Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counsellingS Rudnik-Schöneborn, C Berg, K Zerres, et al.
European Journal of Pediatrics|July 1, 1990
Bare lymphocyte syndrome--combined immunodeficiency and neutrophil dysfunctionN Will, R A Seger, C Betzler, et al.
Frontiers in Cell and Developmental Biology|March 14, 2022
Differential Requirement of Vav Proteins for Btk-dependent and -Independent Signaling During B Cell DevelopmentAnnika C Betzler, Sebastian Kieser, Katja Fiedler, et al.
Neoplasia (New York, N.Y.)|November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cellsAdrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
Journal of Virology|May 7, 2026
Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmissionQinya Xie, Qingxing Wang, Sabrina Noettger, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human diseaseFranziska Oliveri, Linda Neher, Ronja Pscheid, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|May 23, 2022
T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell DifferentiationAnnika C Betzler, Jasmin Ezić, Tsima Abou Kors, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 31, 2015
[Papillary tumors - therapeutic concepts]F C Popp, J Weigt, T Kalinski, et al.
International Journal of Molecular Sciences|June 4, 2020
NF-κB and Its Role in Checkpoint ControlAnnika C Betzler, Marie-Nicole Theodoraki, Patrick J Schuler, et al.
Journal of Medical Genetics|July 30, 2008
Congenital heart disease is a feature of severe infantile spinal muscular atrophyS Rudnik-Schöneborn, R Heller, C Berg, et al.
Clinical Genetics|September 29, 2009
Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counsellingS Rudnik-Schöneborn, C Berg, K Zerres, et al.
European Journal of Pediatrics|July 1, 1990
Bare lymphocyte syndrome--combined immunodeficiency and neutrophil dysfunctionN Will, R A Seger, C Betzler, et al.
Frontiers in Cell and Developmental Biology|March 14, 2022
Differential Requirement of Vav Proteins for Btk-dependent and -Independent Signaling During B Cell DevelopmentAnnika C Betzler, Sebastian Kieser, Katja Fiedler, et al.
Neoplasia (New York, N.Y.)|November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cellsAdrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
Journal of Virology|May 7, 2026
Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmissionQinya Xie, Qingxing Wang, Sabrina Noettger, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human diseaseFranziska Oliveri, Linda Neher, Ronja Pscheid, et al.
Pageof 3